Employer coverage of GLP-1 drugs is collapsing heading into 2027, but the FDA just gave Eli Lilly a specific piece of ammunition that could change the conversation in payer meetings for at least one ...

It is an unsettling question that has emerged alongside the extraordinary rise of the new generation of weight-loss drugs.

The FDA has approved Mounjaro to reduce cardiovascular risk in people with type 2 diabetes after a major trial found it ...

By Nqobile Dludla JOHANNESBURG, Sept 3 (Reuters) - Aspen Pharmacare expects African sales of Eli Lilly's blockbuster weight-loss and diabetes drug Mounjaro to exceed 2 billion rand ($124 million) in ...

For decades, type 2 diabetes was managed with medicines that either pushed insulin higher or improved how the body used it. GLP-1 medicines have changed that pattern. They only stimulate insulin when ...

If you’ve been struggling to lose weight, Saxenda, an injectable weight loss medication, might be able to help. We researched ...

Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug, and medical device regulation, and what we’re reading from around the web. Several ...